Emerging Developments in Targeting Proteotoxicity in Neurodegenerative Diseases.

Emerging Developments in Targeting Proteotoxicity in Neurodegenerative Diseases.
Related ArticlesEmerging Developments in Targeting Proteotoxicity in Neurodegenerative Diseases. CNS Drugs. 2019 Aug 14;: Authors: McAlary L, Plotkin SS, Cashman NR Abstract The most common neurodegenerative diseases are Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease, frontotemporal lobar degeneration, and the motor neuron diseases, with AD affecting approximately 6% of people aged 65 years and older, and PD affecting approximately 1% ... read more
Source: PubMedPublished on 2019-08-16